EMG
SQZ

ETF Managers Group’s SQZ Biotechnologies Company SQZ Stock Holding History

ETF Managers Group’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,631
Closed -$20K – 709
2022
Q3 		$20K Sell
8,631
-262
-3% -$786 ﹤0.01% 690
2022
Q2 		$28K Buy
8,893
+380
+4% +$1.37K ﹤0.01% 729
2022
Q1 		$40K Buy
8,513
+30
+0.4% +$190 ﹤0.01% 668
2021
Q4 		$81K Sell
8,483
-1,648
-16% -$20.2K ﹤0.01% 648
2021
Q3 		$146K Buy
10,131
+1,907
+23% +$25.8K ﹤0.01% 626
2021
Q2 		$114K Sell
8,224
-308
-4% -$4.02K ﹤0.01% 619
2021
Q1 		$110K Sell
8,532
-3,128
-27% -$63.5K ﹤0.01% 633
2020
Q4 		$350K Buy
+11,660
New +$298K 0.01% 518

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

ETF Managers Group's SQZ Position: Q4 2022 in Review

ETF Managers Group sold out of SQZ Biotechnologies Company (SQZ) in Q4 2022, closing a stake of 8,631 shares — an estimated $20K sold.

ETF Managers Group first reported a position in SQZ in Q4 2020 and held it in 8 quarters. The position peaked at $350K in Q4 2020. 36 funds tracked by Wall St. Rank hold SQZ as of Q4 2022.

  • ETF Managers Group reported no remaining SQZ Biotechnologies Company position as of Q4 2022 after selling out during the quarter.
  • ETF Managers Group sold 8,631 SQZ Biotechnologies Company shares in Q4 2022, an estimated $20K.
  • ETF Managers Group first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 8 quarters.
  • ETF Managers Group's SQZ Biotechnologies Company position peaked at $350K in Q4 2020.
  • 36 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q4 2022.

Based on ETF Managers Group's 13F filing for Q4 2022, filed 23 Mar 2023.